PAVmed Inc. (PAVM)

[MaineMan5]

Very positive Business update (link below). Some pretty exciting and transforming catalysts upcoming later this year. If they can partner or sell PortIO and / or NextFlo (which they are trying to do), that would take care of any cash requirements to get their two main devices, CarpX and EsoCheck / EsoGuard, to market without further dilution. Second half of year could (and should) see dramatic increase in SP with total addressable markets for CarpX and EsoCheck over $3B ($1B for CarpX and $2B for EsoCheck), and these are domestic only, not outside US. A little patience may be very well rewarded here over the next 2-4 quarters, notwithstanding my colleague elcheepo who bashes the company at every turn but provides no justification for the negative outlook.

https://finance.yahoo.com/news/pavmed-reports-first-quarter-2019-133000952.html